IP Five in 5 – Teva Sues Cipla over Asthma Drug, EPO Revokes Spinal Therapy Patent and More
Welcome to this edition of MaxVal’s IP Five in 5 – where we cover the
Insights. Ideas. Inspiration.
Welcome to this edition of MaxVal’s IP Five in 5 – where we cover the
MaxVal recently hosted a panel discussion with industry experts Leo Murgel of Salesforce, Ashwin Yadav
When it comes to intellectual property (IP) management systems, often the initial allure is the
Since its adoption in 1989, the Madrid Protocol has facilitated a simplified procedure for securing
Welcome to this edition of IP Five in 5 – where we cover the top
Los Altos, CA, February 14, 2024: MaxVal Group, Inc. (“MaxVal”), a leading provider of intellectual
Los Altos, CA, February 8, 2024: MaxVal Group, Inc. (“MaxVal”), a leading provider of intellectual
The realm of Intellectual Property (IP) management is undergoing a transformative change with the emergence
Welcome to this edition of IP Five in 5 – where we cover the top
In a transformative year for intellectual property, 2023 witnessed significant shifts and advancements across the
The U.S. Patent and Trademark Office (USPTO) bids farewell to the long-standing EFS-Web and Private
Recently, I had the opportunity to sit down with Mary Fox, Co-Founding Partner of Fortem
Subscribe to Our Newsletter!
Sign-up for exclusive content and get the latest IP insights delivered directly to your inbox.